Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Wastewater Surveillance for Poliovirus in Selected Jurisdictions, United States, 2022-2023.
Whitehouse ER, Gerloff N, English R, Reckling SK, Alazawi MA, Fuschino M, St George K, Lang D, Rosenberg ES, Omoregie E, Rosen JB, Kitter A, Korban C, Pacilli M, Jeon T, Coyle J, Faust RA, Xagoraraki I, Miyani B, Williams C, Wendt J, Owens SM, Wilton R, Poretsky R, Sosa L, Kudish K, Juthani M, Zaremski EF, Kehler SE, Bayoumi NS, Kidd S. Whitehouse ER, et al. Among authors: rosen jb. Emerg Infect Dis. 2024 Nov;30(11):2279-2287. doi: 10.3201/eid3011.240771. Emerg Infect Dis. 2024. PMID: 39447148 Free PMC article. Review.
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (Stride-6).
Scott P, Haranaka M, Choi JH, Stacey H, Dionne M, Greenberg D, Grijalva CG, Orenstein WA, Fernsler D, Gallagher N, Zeng T, Li J, Platt HL; STRIDE-6 study group. Scott P, et al. Clin Infect Dis. 2024 Jul 31:ciae383. doi: 10.1093/cid/ciae383. Online ahead of print. Clin Infect Dis. 2024. PMID: 39082735
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial.
Platt HL, Bruno C, Buntinx E, Pelayo E, Garcia-Huidobro D, Barranco-Santana EA, Sjoberg F, Song JY, Grijalva CG, Orenstein WA, Morgan L, Fernsler D, Xu W, Waleed M, Li J, Buchwald UK; STRIDE-3 Study Group. Platt HL, et al. Lancet Infect Dis. 2024 Oct;24(10):1141-1150. doi: 10.1016/S1473-3099(24)00344-X. Epub 2024 Jul 1. Lancet Infect Dis. 2024. PMID: 38964361 Clinical Trial.
Varicella Outbreak Among Recent Arrivals to New York City, 2022-2024.
Graham KA, Arciuolo RJ, Matalka O, Isaac BM, Jean A, Majid N, Seifu L, Croft J, Crouch B, Macaraig M, Lemkin A, Caceres GT, Lall R, Lawrence C, Silverman E, Laraque F, Bouscaren A, Rosen JB. Graham KA, et al. Among authors: rosen jb. MMWR Morb Mortal Wkly Rep. 2024 May 30;73(21):478-483. doi: 10.15585/mmwr.mm7321a1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38814821 Free PMC article. No abstract available.
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study.
Andrejko KL, Gierke R, Rowlands JV, Rosen JB, Thomas A, Landis ZQ, Rosales M, Petit S, Schaffner W, Holtzman C, Barnes M, Farley MM, Harrison LH, McGee L, Chochua S, Verani JR, Cohen AL, Pilishvili T, Kobayashi M. Andrejko KL, et al. Among authors: rosen jb. Vaccine. 2024 Jun 11;42(16):3555-3563. doi: 10.1016/j.vaccine.2024.04.061. Epub 2024 May 3. Vaccine. 2024. PMID: 38704263 Free PMC article.
Antibody Titers against Mpox Virus after Vaccination.
Kottkamp AC, Samanovic MI, Duerr R, Oom AL, Belli HM, Zucker JR, Rosen JB, Mulligan MJ; NYC OSMI Study Group. Kottkamp AC, et al. Among authors: rosen jb. N Engl J Med. 2023 Dec 14;389(24):2299-2301. doi: 10.1056/NEJMc2306239. N Engl J Med. 2023. PMID: 38091537 Free PMC article. No abstract available.
Case 16-2023: A 13-Year-Old Boy with Depression and Hypotension.
Schwartz KR, Donovan AL, Hayes BD, Uchida M, Rosen JB. Schwartz KR, et al. Among authors: rosen jb. N Engl J Med. 2023 May 25;388(21):1992-1999. doi: 10.1056/NEJMcpc2201237. N Engl J Med. 2023. PMID: 37224201 Free PMC article. No abstract available.
Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January-June 2021.
Peebles K, Arciuolo RJ, Romano AS, Sell J, Greene SK, Lim S, Mulready-Ward C, Ternier A, Badenhop B, Blaney K, Real JE, Spencer M, McPherson TD, Ahuja SD, Sullivan Meissner J, Zucker JR, Rosen JB. Peebles K, et al. Among authors: rosen jb. J Infect Dis. 2023 Feb 14;227(4):533-542. doi: 10.1093/infdis/jiac448. J Infect Dis. 2023. PMID: 36626187 Free PMC article.
164 results